insights_auto
Outlook: 83.7% bullish·0.0% bearish
Go to analysischevron_right
GMAB:NASDAQ
Genmab A/S - ADR
$57.06
arrow_upward
+1.01%(+0.57) 1D
$57.07
arrow_upward
+0.02% (+0.0100)bedtimeAfter hours
Closed: Oct 30, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$57.40
High
$59.02
Low
$56.53
Mkt. cap
35.64B
Avg. vol.
5.40M
Volume
8.65M
P/E ratio
44.96
52-wk high
$59.97
52-wk low
$23.62
EPS
$1.27
Beta
0.81
Shares outstanding
624.06M
No. of employees
3K
Open
$57.40
High
$59.02
Low
$56.53
Mkt. cap
35.64B
Avg. vol.
5.40M
Volume
8.65M
P/E ratio
44.96
52-wk high
$59.97
52-wk low
$23.62
EPS
$1.27
Beta
0.81
Shares outstanding
624.06M
No. of employees
3K
News stories
From web sources and news partners
Investing.com
·
1 day ago
H.C. Wainwright raises Genmab stock price target to $70 on trial data
BioPharma Dive
·
1 day ago
Genmab soars to record highs after cancer drug succeeds in key trial
Stocktwits
·
2 days ago
Why Did ETSY, REPL, GMAB Stocks Surge To 52-Week Highs Today?
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com